Just a moment, the page is loading...

GSK-MY-1043/BRL-029060/115




A multicenter, randomized, double-blind, placebo-controlled comparison of paroxetine and fluoxetine in the treatment of major depressive disorder.
paroxetine
MY-1043/BRL-029060/115
Depressive Disorder, Major
Phase 3
An analysis-ready dataset is not available for this study. An annotated case report form and a reporting and analysis plan are not available for this study. A link to ClinicalTrials.gov and an NCTID number are not available for this study because the study is not in scope of regulatory requirements to register studies.
May 2014